Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() eConsent Promises Advancement of Patient-Centricity and Data Integrity in Clinical TrialsBy: Clinical ink In a groundbreaking development, electronic informed consent (eConsent) platforms have emerged as a game-changer in the world of clinical trials. Sponsors and sites are reaping remarkable benefits from incorporating these cutting-edge tools into their operations, revolutionizing the consent process and elevating the overall trial experience for everyone involved. eConsent platforms streamline and simplify the consent process for study participants, resulting in enhanced engagement and comprehension. It presents information in a clear and accessible manner, and participants are better equipped to make informed decisions about their involvement in the study, leading to improved study enrollment and retention rates. Empowering Patients, Streamlining Workflow In a significant stride towards patient-centric clinical trials, eConsent platforms are proving to be a game-changer for both patients and researchers. These innovative platforms empower patients through easy-to-follow, patient-friendly eConsent forms that provide tiered information and include knowledge checks. With reconsenting triggers, graphical and video content, and translation into over 40 native languages, eConsent ensures that patients have a comprehensive understanding of their participation in the trial, enabling them to make informed decisions with confidence. Furthermore, eConsent is streamlining workflow processes, enhancing the overall efficiency of clinical trials. Its dynamic visit creation and conditional logic capabilities optimize workflows across various trial stages. By integrating seamlessly eSource technology, including DDC (https://www.clinicalink.com/ The Future Will Be Digital electronic consent clinical trials (https://www.clinicalink.com/ As a key component of Clinical Ink's eSource technology, eConsent clinical trials play a pivotal role in raising patient comprehension, streamlining workloads for sites and study teams, and improving data quality to support informed decision-making and regulatory compliance. With its dynamic and intuitive design, eConsent ensures a seamless and user-friendly experience for both patients and clinicians. This fosters patient understanding, promotes compliance, and instills trust among healthcare professionals throughout the trial journey. Embracing eConsent heralds a new era of patient-centric clinical trials, offering significant improvements in efficiency, data accuracy, and overall trial success. End
|
|